Advertisement Pharmaceutical Business review - Page 619 of 5260 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
February 13, 2026

Amgen receives EC approval for Uplizna in generalised myasthenia gravis

Amgen has secured approval from the European Commission (EC) for Uplizna (inebilizumab) as an add-on treatment to standard therapy for adults with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positive.

Continue
MINT enrolled 238 adults with gMG, including 190 AChR+ and 48 MuSK+ patients. Credit: luchschenF / Shutterstock.com.
February 13, 2026

Ampersand Capital acquires Purna Pharmaceuticals

The MedPharm-Purna partnership could become a preferred trans-Atlantic provider for development of topical and transdermal pharmaceutical products. Credit: Krisana Antharith / Shutterstock.com.
February 12, 2026

Citius Oncology and Uniphar sign European distribution deal for Lymphir

Lymphir is a targeted immunotherapy for relapsed or refractory CTCL. Credit: Nemes Laszlo / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. MSD receives FDA approval for Keytruda combo to treat ovarian cancer
  2. THX Pharma and Biocodex sign licensing deal for Batten-1 and TX01 drugs
  3. Insilico and CMS launch drug discovery collaborations for CNS diseases
  4. REGENXBIO receives FDA response for RGX-121 application
  5. Takeda and Iambic announce $1.7bn deal to advance small molecule programmes

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography